Recombinant Dictyostelium discoideum Putative actin-28 (act28)from MyBiosource |
|
| MBS1390723-002mgBaculovirus | 0.02mg(Baculovirus): 1230.00 EUR |
|
Recombinant Dictyostelium discoideum Putative actin-28 (act28)from MyBiosource |
|
| MBS1390723-002mgEColi | 0.02mg(E-Coli): 890.00 EUR |
|
Recombinant Dictyostelium discoideum Putative actin-28 (act28)from MyBiosource |
|
| MBS1390723-002mgYeast | 0.02mg(Yeast): 1020.00 EUR |
|
Recombinant Dictyostelium discoideum Putative actin-28 (act28)from MyBiosource |
|
| MBS1390723-01mgEColi | 0.1mg(E-Coli): 1070.00 EUR |
|
Recombinant Dictyostelium discoideum Putative actin-28 (act28)from MyBiosource |
|
| MBS1390723-01mgYeast | 0.1mg(Yeast): 1160.00 EUR |
|
Macitentan (ACT 064992; ACT-064992)from MyBiosource |
|
| MBS132402-100mg | 100mg: 1065.00 EUR |
|
Macitentan (ACT 064992; ACT-064992)from MyBiosource |
|
| MBS132402-500mg | 500mg: 2775.00 EUR |
|
ACT-1004-1239from MedChemExpress |
|
| HY-142617 | 10 mg: 3733.82 EUR |
|
|
Description: ACT-1004-1239 is a potent, selective, orally active CXCR7 antagonist with an IC50 value of 3.2 nM[1][2]. |
|
ACT-1004-1239from MyBiosource |
|
| MBS5800098-5mg | 5(mg: 915.00 EUR |
|
ACT-1004-1239from MyBiosource |
|
| MBS5800098-5x5mg | 5x5(mg: 3970.00 EUR |
|
ACT-1004-1239from TargetMol Chemicals |
|
| T39665-10mg | 10mg: Ask for price |
|
|
Description: ACT-1004-1239 |
|
ACT-1004-1239from TargetMol Chemicals |
|
| T39665-1g | 1g: Ask for price |
|
|
Description: ACT-1004-1239 |
|
ACT-1004-1239from TargetMol Chemicals |
|
| T39665-1mg | 1mg: Ask for price |
|
|
Description: ACT-1004-1239 |
|
ACT-1004-1239from TargetMol Chemicals |
|
| T39665-50mg | 50mg: Ask for price |
|
|
Description: ACT-1004-1239 |
|
ACT-1004-1239from TargetMol Chemicals |
|
| T39665-5mg | 5mg: Ask for price |
|
|
Description: ACT-1004-1239 |
|
ACT-703328from MedKoo Biosciences |
|
| 555627 | 500.0mg: 2950.00 EUR |
|
ACT-709478from MedKoo Biosciences |
|
| 530984 | 200.0mg: 2450.00 EUR |
|
ACT-462206from MedKoo Biosciences |
|
| 531401 | 10.0mg: 400.00 EUR |
|
ACT-451840from MedKoo Biosciences |
|
| 571533 | 1.0mg: 80.00 EUR |
|
ACT-335827from MedKoo Biosciences |
|
| 563140 | 10.0mg: 550.00 EUR |
|
ACT-678689from MedKoo Biosciences |
|
| 563700 | 100.0mg: 1850.00 EUR |
|
ACT-389949from MedKoo Biosciences |
|
| 462068 | 25.0mg: 850.00 EUR |
|
ACT-132577from ApexBio |
|
| B3279-10 | 10 mg: 616.00 EUR |
|
|
Description: ETA/ETB receptors antagonist |
|
ACT-132577from ApexBio |
|
| B3279-100 | 100 mg: 4620.00 EUR |
|
|
Description: ACT-132577 is a dual antagonist of ETA and ETB receptors with IC50 values of 3.4nM and 987nM, respectively [1].ACT-132577 is a major metabolite of macitentan which is a dual ET receptor antagonist with strong affinity for the tissues. |
|
ACT-132577from ApexBio |
|
| B3279-2 | 2mg: 287.20 EUR |
|
|
Description: ETA/ETB receptors antagonist |
|
ACT-132577from ApexBio |
|
| B3279-5 | 5 mg: 430.40 EUR |
|
|
Description: ETA/ETB receptors antagonist |
|
ACT-132577from ApexBio |
|
| B3279-5.1 | 10 mM (in 1mL DMSO): 973.20 EUR |
|
|
Description: ACT-132577 is a dual antagonist of ETA and ETB receptors with IC50 values of 3.4nM and 987nM, respectively [1].ACT-132577 is a major metabolite of macitentan which is a dual ET receptor antagonist with strong affinity for the tissues. |
|
ACT-132577from ApexBio |
|
| B3279-50 | 50 mg: 1846.40 EUR |
|
|
Description: ETA/ETB receptors antagonist |
|
ACT-129968from Biovision |
|
| B2316-10 | each: 170.40 EUR |
|
ACT-129968from Biovision |
|
| B2316-50 | each: 496.80 EUR |
|
ACT-678689from MyBiosource |
|
| MBS131416-100mg | 100mg: 1495.00 EUR |
|
ACT-389949from MyBiosource |
|
| MBS133006-INQUIRE | INQUIRE: Ask for price |
|
ACT-678689from MedChemExpress |
|
| HY-19572 | 1mg: 405.85 EUR |
|
|
Description: ACT-678689 (Compound Example 1.53.4) is a tryptophan hydroxylase (TPH) inhibitor with an IC50 of 8 nM[1]. |
|
ACT-660602from MedChemExpress |
|
| HY-151096 | 10 mg: 2759.78 EUR |
|
|
Description: ACT-660602 is an orally active antagonist of chemokine receptor (CXCR3) with an IC50 value of 204 nM. ACT-660602 inhibits T-cell migration and shows efficacy in acute lung ingury model. ACT-660602 can be used for autoimmune diseases research[1][2]. |
|
ACT-672125from MedChemExpress |
|
| HY-153240 | Get quote: Ask for price |
|
|
Description: ACT-672125 is a potent CXCR3 antagonist with IC50 value of 239 nM in human blood. ACT-672125 has activity for hERG with IC50 value of 18μM. ACT-672125 can be used for the research of autoimmune diseases[1]. |
|
ACT-373898from MedChemExpress |
|
| HY-135500 | 10mg: Ask for price |
|
|
Description: ACT-373898 is an inactive carboxylic acid metabolite of Macitentan. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist[1]. |
|
ACT-462206from MedChemExpress |
|
| HY-101834 | 10 mg: 616.89 EUR |
|
|
Description: ACT-462206 is an orally active and potent dual Orexin 1/Orexin 2 receptor antagonist with IC50s of 60 nM (Orexin 1) and 11 nM (Orexin 2), respectively. ACT-462206 exhibits brain penetration properties, and can be used for insomnia, stress/anxiety-related disorders and addiction research[1]. |
|
ACT-335827from MedChemExpress |
|
| HY-108683 | 5 mg: 790.06 EUR |
|
|
Description: ACT-335827 is a selective, orally active, brain-penetrant orexin type 1 receptor antagonist. ACT-33582 acts on OXR1 and OXR2 with IC50 values of 6 nM and 417 nM, respectively. ACT-33582 can be used in studies related to neurological disorders[1]. |
|
ACT-451840from MedChemExpress |
|
| HY-111817 | 10 mg: 1461.06 EUR |
|
|
Description: ACT-451840 is an orally active, potent and low-toxicity compound, showing activity against sensitive and resistant plasmodium falciparum strains. ACT-451840 targets all asexual blood stages of the parasite, has a rapid onset of action. ACT-451840 behaves in a way similar to artemisinin derivatives, with very rapid onset of action and elimination of parasite. ACT-451840 can be used for the research of malarial[1][2][3]. |
|
ACT-209905from MedChemExpress |
|
| HY-12616 | Get quote: Ask for price |
|
|
Description: ACT-209905 is a S1P1 receptor agonist. ACT-209905 can inhibit glioblastoma (GBM) cell growth and migration. ACT-209905 also has immunomodulating activity, and can be used in research of autoimmune diseases[1]. |
|
ACT-389949from MedChemExpress |
|
| HY-124071 | 1 mg: 1785.74 EUR |
|
|
Description: ACT-389949 is a first-in-class, potent and selective and agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes. ACT-389949 has potential for the treatment of inflammatory disorders[1][2]. |
|
ACT-777991from MedChemExpress |
|
| HY-149055 | Get quote: Ask for price |
|
|
Description: ACT-777991 is an orally active and selective CXCR3 antagonist. ACT-777991 has microsomes and hepatocytes stability across animal models. ACT-777991 inhibits the migration of activated T cells toward CXCL11[1]. |
|
ACT-606559from MedChemExpress |
|
| HY-141621 | Get quote: Ask for price |
|
|
Description: ACT-606559, a new chemical entity with antimalarial activity, is a metabolite of ACT451840. ACT-606559 can be used for the research of malarial[1]. |
|
ACT-335827from MyBiosource |
|
| MBS3840044-10mg | 10mg: 240.00 EUR |
|
ACT-335827from MyBiosource |
|
| MBS3840044-25mg | 25mg: 405.00 EUR |
|
ACT-335827from MyBiosource |
|
| MBS3840044-50mg | 50mg: 635.00 EUR |
|
ACT-335827from MyBiosource |
|
| MBS3840044-5x50mg | 5x50mg: 2845.00 EUR |
|
ACT-709478from MyBiosource |
|
| MBS3843953-100mg | 100mg: 5835.00 EUR |
|
ACT-709478from MyBiosource |
|
| MBS3843953-10mg | 10mg: 1045.00 EUR |
|
ACT-709478from MyBiosource |
|
| MBS3843953-50mg | 50mg: 2965.00 EUR |
|
ACT-709478from MyBiosource |
|
| MBS3843953-5mg | 5mg: 630.00 EUR |
|
ACT-709478from MyBiosource |
|
| MBS3843953-5x100mg | 5x100mg: 26245.00 EUR |
|
ACT-709478from MyBiosource |
|
| MBS5754476-100mg | 100mg: 4445.00 EUR |
|
ACT-709478from MyBiosource |
|
| MBS5754476-10mg | 10mg: 1020.00 EUR |
|
ACT-709478from MyBiosource |
|
| MBS5754476-50mg | 50mg: 3115.00 EUR |
|
ACT-709478from MyBiosource |
|
| MBS5754476-5x100mg | 5x100mg: 19865.00 EUR |
|
ACT-389949from MyBiosource |
|
| MBS5764580-10mg | 10mg: 520.00 EUR |
|
ACT-389949from MyBiosource |
|
| MBS5764580-1mg | 1mg: 240.00 EUR |
|
ACT-389949from MyBiosource |
|
| MBS5764580-25mg | 25mg: 785.00 EUR |
|
ACT-389949from MyBiosource |
|
| MBS5764580-50mg | 50mg: 1280.00 EUR |
|
ACT-389949from MyBiosource |
|
| MBS5764580-5mg | 5mg: 380.00 EUR |
|
ACT-678689from MyBiosource |
|
| MBS5765572-10mg | 10mg: 510.00 EUR |
|
ACT-678689from MyBiosource |
|
| MBS5765572-1mg | 1mg: 225.00 EUR |
|
ACT-678689from MyBiosource |
|
| MBS5765572-25mg | 25mg: 925.00 EUR |
|
ACT-678689from MyBiosource |
|
| MBS5765572-50mg | 50mg: 1345.00 EUR |
|
ACT-678689from MyBiosource |
|
| MBS5765572-5mg | 5mg: 350.00 EUR |
|
ACT-209905from MyBiosource |
|
| MBS5776286-5mg | 5(mg: 915.00 EUR |
|
ACT-209905from MyBiosource |
|
| MBS5776286-5x5mg | 5x5(mg: 3970.00 EUR |
|
ACT-387042from MyBiosource |
|
| MBS5776287-5mg | 5(mg: 915.00 EUR |
|
ACT-387042from MyBiosource |
|
| MBS5776287-5x5mg | 5x5(mg: 3970.00 EUR |
|
ACT-462206from MyBiosource |
|
| MBS5776288-10mg | 10(mg: 360.00 EUR |
|
ACT-462206from MyBiosource |
|
| MBS5776288-50mg | 50mg: 1400.00 EUR |
|
ACT-462206from MyBiosource |
|
| MBS5776288-5x50mg | 5x50mg: 6155.00 EUR |
|
ACT-451840from MyBiosource |
|
| MBS5773391-5mg | 5mg: 915.00 EUR |
|
ACT-451840from MyBiosource |
|
| MBS5773391-5x5mg | 5x5mg: 3970.00 EUR |
|
ACT-373898from MyBiosource |
|
| MBS5796943-10mg | 10(mg: 290.00 EUR |
|
ACT-373898from MyBiosource |
|
| MBS5796943-1mg | 1(mg: 135.00 EUR |
|
ACT-373898from MyBiosource |
|
| MBS5796943-5mg | 5(mg: 215.00 EUR |
|
ACT-660602from TargetMol Chemicals |
|
| T63761-10mg | 10mg: Ask for price |
|
|
Description: ACT-660602 |
|
ACT-660602from TargetMol Chemicals |
|
| T63761-1g | 1g: Ask for price |
|
|
Description: ACT-660602 |
|
ACT-660602from TargetMol Chemicals |
|
| T63761-1mg | 1mg: Ask for price |
|
|
Description: ACT-660602 |
|
ACT-660602from TargetMol Chemicals |
|
| T63761-50mg | 50mg: Ask for price |
|
|
Description: ACT-660602 |
|
ACT-660602from TargetMol Chemicals |
|
| T63761-5mg | 5mg: Ask for price |
|
|
Description: ACT-660602 |
|
ACT-373898from TargetMol Chemicals |
|
| T35623-10mg | 10mg: Ask for price |
|
|
Description: ACT-373898 |
|
ACT-373898from TargetMol Chemicals |
|
| T35623-1g | 1g: Ask for price |
|
|
Description: ACT-373898 |
|
ACT-373898from TargetMol Chemicals |
|
| T35623-1mg | 1mg: Ask for price |
|
|
Description: ACT-373898 |
|
ACT-373898from TargetMol Chemicals |
|
| T35623-50mg | 50mg: Ask for price |
|
|
Description: ACT-373898 |
|
ACT-373898from TargetMol Chemicals |
|
| T35623-5mg | 5mg: Ask for price |
|
|
Description: ACT-373898 |
|
Gynecologic cytology, Lung, Thyroid, Liver & Pancreas